Bulletin
Investor Alert

Mirum Pharmaceuticals Inc.

NAS: MIRM

GO
/marketstate/country/us

After Hours

/zigman2/quotes/213233695/composite

$

15.21

Change

0.00 0.00%

Volume

Volume 4

Oct 22, 2021, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/213233695/composite

Previous close

$ 15.75

$ 15.21

Change

-0.54 -3.43%

Day low

Day high

$14.95

$15.67

Open
Open: 15.61

52 week low

52 week high

$13.85

$26.31

Open

Market cap

$464.15M

Average volume

231,188

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-5.41

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mirm

MarketWatch News on MIRM

  1. Mirum Pharmaceuticals started at overweight with $30 stock price target at J.P. Morgan

    6:54 a.m. Sept. 20, 2021

    - Tomi Kilgore

  2. Mirum Pharmaceuticals started at outperform with $28 stock price target at Raymond James

    7:45 a.m. Aug. 12, 2019

    - Tomi Kilgore

  3. Immersion, Acacia, Lennar, and Other 13D Filings

    9:30 p.m. Aug. 2, 2019

    - Barron's Online

  4. Mirum Pharmaceuticals sets IPO terms, to offer 5 mln shares priced at $14 to $16 each

    6:51 a.m. July 8, 2019

    - Ciara Linnane

/news/nonmarketwatch/company/us/mirm

Other News on MIRM

  1. Biotech's big fall catalysts to watch out for, from Evercore

    9:35 a.m. Sept. 24, 2021

    - Seeking Alpha

  2. 10-Q: MIRUM PHARMACEUTICALS, INC.

    5:22 p.m. Aug. 5, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  3. Mirum: Rare Disease Play With Upcoming Catalysts

    8:00 a.m. May 18, 2021

    - Seeking Alpha

  4. 10-Q: MIRUM PHARMACEUTICALS, INC.

    4:22 p.m. May 6, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  5. Loading more headlines...
/news/pressrelease/company/us/mirm

Press Releases on MIRM

  1. Mirum Pharmaceuticals to Participate in September Investor Conferences

    5:30 p.m. Sept. 2, 2021

    - BusinessWire - BZX

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.